UAE Left Ventricular Assist Devices (LVADs) Market Share, Size & Competitive Landscape Report 2030

UAE Left Ventricular Assist Devices (LVADs) Market Size & Insights
As per recent study by MarkNtel Advisors The UAE Left Ventricular Assist Devices (LVADs) Market size was valued at around USD 391.29 million in 2024 and is projected to reach USD 511.22 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 4.45% during the forecast period, i.e., 2025-30.
What are the Key DROs in the UAE Left Ventricular Assist Devices (LVADs) Market?
Increasing Prevalence of Heart Failure in the UAE – Increasing heart failure rate is the primary factor driving the growth of the left ventricular assist device market in the United Arab Emirates. Coronary heart disease leads to maximum deaths in UAE with 40% of all fatalities attributed to cardiovascular diseases in this country as per the Ministry of Health and Prevention. Since Heart failure is common in the aged population, hence modern treatments like LVADs are required. By the end of 2050, there is a probability of 2 million people in the United Arab Emirates to be 60 years of age or older. It is expected that this demographic shift will similarly increase demand for LVADs as heart failure will become more frequent in older adults. Similarly contributing to the rising prevalence of coronary heart failure are lifestyle factors including obesity rates that surpass 28% and the roughly 50% of individuals being overweight. The need for LVADs is similarly increased by a sedentary lifestyle that increases heart-related troubles.
What are the Key Segments in the UAE Left Ventricular Assist Devices (LVADs) Market?
The UAE Left Ventricular Assist Devices (LVADs) is categorized into notable segments, which help in understanding the structure, dynamics, and opportunities within the market. These segments are typically based on:
- By Type of Flow
- Pulsatile Flow - Market Size & Forecast 2020-2030, USD Million
- Non-Pulsatile Flow - Market Size & Forecast 2020-2030, USD Million
- By Design
- Implantable Ventricular Assist Devices - Market Size & Forecast 2020-2030, USD Million
- Transcutaneous Ventricular Assist Devices - Market Size & Forecast 2020-2030, USD Million
- By Application
- Bridge to Transplantation - Market Size & Forecast 2020-2030, USD Million
- Destination Therapy - Market Size & Forecast 2020-2030, USD Million
- Bridge to Recovery - Market Size & Forecast 2020-2030, USD Million
- Bridge to Candidacy - Market Size & Forecast 2020-2030, USD Million
Boost Your Company's Decisions by Getting a Free Sample Right Away- https://www.marknteladvisors.com/query/request-sample/uae-lvads-market.html
By Region
- Dubai
- Abu Dhabi
- Sharjah
- Northern Emirates
Who are the Key Players in UAE Left Ventricular Assist Devices (LVADs) Market?
Abbott Laboratories, Cadrenal Therapeutics, Fresenius Medical Care AG & Co. KgaA, Abiomed Inc., Teleflex Incorporated, SynCardia Systems, CardiacAssist, Inc., Jarvik 2000, Reliant Heart, Edwards Lifesciences, GE Healthcare, and others
Browse Full Reports: https://www.marknteladvisors.com/research-library/uae-lvads-market.html
UAE Left Ventricular Assist Devices (LVADs) Market News
- August 2024: Abbott and Cadrenal Therapeutics are exploring a collaboration on a pivotal study to assess tecarfarin's safety and efficacy in preventing blood clots in patients with newly implanted LVADs, aiming to improve anticoagulation treatment..
Key pillars of the research methodology include:
· Scope & Research Design – Clearly defined objectives with tailored qualitative and quantitative methods, backed by precise timelines and budgets.
· Sample Selection & Data Collection – Representative samples achieved through proven techniques like random and stratified sampling, supported by reliable tools such as surveys, interviews, and observations.
· Data Analysis & Validation – Rigorous cleaning, advanced statistical modeling, and thematic analysis ensure accuracy, reliability, and minimal bias.
- Forecasting & Finalization – Predictive modeling and time-series analysis anticipate future market behaviors, presented through insightful reports with charts, graphs, and strategic recommendations.
"Our methodology reflects the trust businesses place in us. By combining innovation with precision, we deliver not just numbers, but clarity and direction for decision-makers worldwide," said a spokesperson for MarkNtel Advisors.
Why This MarkNtel Advisors Research Report:
- In-depth Market Analysis: Understand trends and dynamics shaping growth.
- Segmented Insights: Target specific segments for focused strategies.
- Geographical Performance: Assess market opportunities by geographic area.
- Emerging Technologies: Discover advancements like AI integration.
- Risk Identification: Pinpoint challenges to inform strategic planning.
- Future Forecasts: Prepare for market changes with actionable projections.
Gain exclusive access to our comprehensive insights on the UAE Left Ventricular Assist Devices (LVADs) Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.
Select a License That Matches Your Business Requirements with Instant Offer - https://www.marknteladvisors.com/pricing/uae-lvads-market.html
Our Trusted Experts Are Here to Help:
At MarkNtel Advisors, we are committed to delivering data-driven insights and strategic intelligence that empower your business decisions. Whether you have a question, need customized research, or want to explore partnership opportunities, our team is here to support you every step of the way.
Reach Us:
MarkNtel Advisors
Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 8719999009
Email: sales@marknteladvisors.com
Visit our Website: https://www.marknteladvisors.com
We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.